Tag Archives: Major Depressive Disorder (MDD)

H. Lundbeck A/S, Takeda announced that US FDA accepted a supplemental New Drug Application (sNDA) for review of Brintellix (vortioxetine)

Valby, Denmark and Osaka, Japan, 12-8-2015 — /EuropaWire/ — H. Lundbeck A/S (Lundbeck) and Takeda Pharmaceutical Company Limited (Takeda) announced today the US Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for review to add … Read the full press release